Last edition
News about Industrial talks
Wockhardt arm partners with Jemincare for novel respiratory antibiotic nafithromycin
Wockhardt Bio AG - a subsidiary of Wockhardt Limited, a worldwide leader in discovery of novel antibiotics and Jiangxi Jemincare Group Company Limited, China, have partnered for Wockhardt's novel patented antibiotic WCK 4873 (nafithromycin) in People's Republic of China, Hong Kong, Macau and Taiwan for the treatment of community-acquired bacterial
Industrial talks | 26/08/2021 | By Darshana | 414
Vertex Pharma, Arbor enter new collaboration to develop novel ex vivo engineered cell therapies
Vertex Pharmaceuticals Incorporated, a global biotechnology company, and Arbor Biotechnologies (Arbor), an early-stage life sciences company, announced a new collaboration to enhance efforts in developing ex vivo engineered cell therapies, using Arbor's proprietary CRISPR gene-editing technology for select diseases
Industrial talks | 25/08/2021 | By Darshana | 370
FPME: Pharma exporters ignored under chapter 29 and 30 for RoDTEP rates
The Federation of Pharmaceutical Merchant Exporters and Allied Products (FPME) stated that pharmaceutical exporters are feeling neglected and taken for granted under Remission of Duties and Taxes on Exported Products (RoDTEP), as no rates were announced under chapter 29 and 30 by the Directorate General of Foreign Trade (DGFT)
Industrial talks | 24/08/2021 | By Darshana | 441
Serum Institute picks up 50% in glass vial maker Schott's Indian JV
Vaccine maker Serum Institute of India (SII) has picked up a 50 per cent stake in specialty glass company Schott AG's Indian joint venture, Schott Kaisha, from the former co-owners Kairus Dadachanji and Shapoor Mistry for an undisclosed sum
Industrial talks | 21/08/2021 | By Darshana | 620
F&S notes global medical imaging & informatics market thrives with AI and cloud to spur growth
Frost & Sullivan has noted that the healthcare sector's emphasis on meeting its Quadruple Aim goal of cost reduction, clinical outcomes, enhance the patient and caregiver experience, and improve the work-life of its medical professionals, nurses and paramedics encourages the medical imaging and informatics industry to use advanced technologies
Industrial talks | 12/08/2021 | By Darshana | 237
Cipla receives US FDA approval for generic Durezol
Cipla Limited has received final approval for its Abbreviated New Drug Application (ANDA) for difluprednate ophthalmic emulsion 0.05% from the United States Food and Drug Administration (FDA)
Industrial talks | 12/08/2021 | By Darshana | 208
IPC flags safety alerts against etoricoxib, torsemide and quetiapine & valproic acid interaction
The Indian Pharmacopoeia Commission (IPC) which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) has flagged safety alerts against etoricoxib, torsemide and quetiapine & valproic acid interaction.
Industrial talks | 09/08/2021 | By Darshana | 503
Kite inks research pact with Appia Bio to develop allogeneic cell therapies
Kite, a Gilead Company and Appia Bio, an early stage biotechnology company, announced a collaboration and license agreement to research and develop HSC-derived cell therapies directed toward hematological malignancies. Under the partnership, Kite and Appia Bio will develop chimeric antigen receptor
Industrial talks | 07/08/2021 | By Darshana | 187
Accelerate Diagnostics announced that the new IVD configuration of its Accelerate PhenoTest BC kit has been CE marked and is ready for use in Europe
Industrial talks | 06/08/2021 | By Darshana | 272
NPPA directs manufacturers and importers of five medical devices to submit data every quarter
The National Pharmaceutical Pricing Authority (NPPA) has directed the manufacturers and importers of the five medical devices it has recently imposed a trade margin cap of 70 per cent to submit quarterly stock details within 10 days from the completion of the quarter, till the time the notification is in force
Industrial talks | 30/07/2021 | By Darshana | 334
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy